AFFERENT MEDICAL SOLUTIONS LTD

Active United Kingdom

Other research and experimental development on natural sciences and engineering

3 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

AFFERENT MEDICAL SOLUTIONS LTD

Other research and experimental development on natural sciences and engineering

Founded 29 Jul 2019 Active United Kingdom 3 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

AFFERENT ELECTRONICS LTD 29 Jul 2019 — 2 Mar 2020
Accounts Submitted 24 Apr 2026 Next due 30 Apr 2026 19 days overdue
Confirmation Submitted 28 Jul 2025 Next due 11 Aug 2026 2 months remaining
Net assets £173K £47K 2024 year on year
Total assets £187K £125K 2024 year on year
Total Liabilities £14K £79K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for AFFERENT MEDICAL SOLUTIONS LTD (12126455), an active life sciences and medical technology company based in United Kingdom. Incorporated 29 Jul 2019. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£184.07k

Decreased by £111.16k (-38%)

Net Assets

£172.72k

Decreased by £46.58k (-21%)

Total Liabilities

£14.41k

Decreased by £78.87k (-85%)

Turnover

N/A

Employees

3

Decreased by 2 (-40%)

Debt Ratio

8%

Decreased by 22 (-73%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2021Seed
Investor 2Feb 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 245,417 Shares £627k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Mar 202247,651£375k£7.87
22 Mar 202231,766£250k£7.87
28 May 2020166,000£2k£0.01

Officers

Officers

2 active 1 resigned
Status
Aliaksandr GourineDirectorBritishEngland5327 May 2020Active
Kenneth Michael SpyerDirectorBritishEngland821 May 2022Active

Shareholders

Shareholders (8)

Andrey Gourine
34.1%
Allaksandr Gourine
20.2%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Andrey Gourine

French

Active
Notified 29 Jul 2019
Residence Sweden
DOB July 1964
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Allaksandr Gourine

Ceased 1 Sept 2023

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
11 Mar 2026OfficersTermination of Everard Joseph Philip Mascarenhas as director on 9 Mar 2026
1 Aug 2025Persons With Significant ControlCessation of Allaksandr Gourine as a person with significant control on 1 Sept 2023
28 Jul 2025Confirmation StatementConfirmation statement made on 28 Jul 2025 with no updates
30 Apr 2025AccountsAnnual accounts made up to 31 Jul 2024
24 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

11 Mar 2026 Officers

Termination of Everard Joseph Philip Mascarenhas as director on 9 Mar 2026

1 Aug 2025 Persons With Significant Control

Cessation of Allaksandr Gourine as a person with significant control on 1 Sept 2023

28 Jul 2025 Confirmation Statement

Confirmation statement made on 28 Jul 2025 with no updates

30 Apr 2025 Accounts

Annual accounts made up to 31 Jul 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

3 weeks ago on 24 Apr 2026

Termination of Everard Joseph Philip Mascarenhas as director on 9 Mar 2026

2 months ago on 11 Mar 2026

Cessation of Allaksandr Gourine as a person with significant control on 1 Sept 2023

9 months ago on 1 Aug 2025

Confirmation statement made on 28 Jul 2025 with no updates

9 months ago on 28 Jul 2025

Annual accounts made up to 31 Jul 2024

1 years ago on 30 Apr 2025